IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,734 | -86.4% | 381 | -79.0% | 0.00% | -100.0% |
| Q2 2023 | $12,771 | +24.1% | 1,814 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $10,290 | -4.4% | 1,684 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $10,761 | +976.1% | 1,684 | +1175.8% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 132 | -49.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 259 | -7.8% | 0.00% | – |
| Q1 2022 | $4,000 | -78.9% | 281 | -72.4% | 0.00% | -100.0% |
| Q4 2021 | $19,000 | 0.0% | 1,017 | +31.6% | 0.00% | -33.3% |
| Q3 2021 | $19,000 | +216.7% | 773 | +239.0% | 0.00% | +200.0% |
| Q2 2021 | $6,000 | +200.0% | 228 | +240.3% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 67 | +3.1% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +200.0% | 65 | +91.2% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 34 | -77.3% | 0.00% | -100.0% |
| Q1 2020 | $4,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |